BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 110050
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110050
Table 1 Baseline demographic and clinical characteristics of patients undergoing laparoscopic vs open surgery for complex hepatolithiasis, n (%)
Variable
Laparoscopic group (n = 40)
Open surgery group (n = 40)
χ2/t/Mann-Whitney U test
P value
Age (years, mean ± SD), (range)52.7 ± 12.1 (23.0-81.0)56.1 ± 12.9 (34.0-80.0)-1.2150.228
Sex
Female24 (60.0)26 (65.0)0.2130.644
Male16 (40.0)14 (35.0)--
BMI (kg/m2, IQR)20.0 (18.0-21.0)20.0 (19.0-22.5)-0.9980.318
Hepatitis B8 (20.0)7 (17.5)0.0820.775
Malnutrition6 (15.0)8 (20.0)0.3460.556
Diabetes6 (15.0)7 (17.5)0.0920.762
Presentation
Acute cholangitis37 (92.5)36 (90.0)-1.0001
Acute pancreatitis9 (22.5)8 (20.0)0.0750.785
Liver abscess12 (30.0)15 (37.5)0.5030.478
Lung abscess2 (5.0)1 (2.5)-1.0001
Previous operation
Cholecystectomy34 (85.0)35 (87.5)0.1050.745
Bilioenteric anastomosis7 (17.5)7 (17.5)0.0001.000
Exploration of bile duct35(87.5)33 (82.5)0.3920.531
Hepatectomy10 (25.0)11 (27.5)0.0650.799
Concomitant condition
Gallbladder stones3 (7.5)4 (10.0)-1.0001
Extrahepatic biliary stones34 (85.0)33 (82.5)0.0920.762
Hepatic atrophy12 (30.0)15 (37.5)0.5030.478
Cirrhosis6 (15.0)7 (17.5)0.0920.762
Intrahepatic biliary stricture38 (95.0)38 (95.0)-1.0001
Table 2 Comparison of intraoperative parameters, postoperative outcomes, and complications between the laparoscopic and open surgery groups, n (%)
Variables
Laparoscopic group (n = 40)
Open surgery group (n = 40)
χ2/Mann-Whitney U test
P value
Left lateral sectionectomy5 (12.5)5 (12.5)0.0001.000
Periportal hepatectomy3 (7.5)3 (7.5)-1.0001
Left hepatectomy6 (15.0)3 (7.5)-0.4811
Right posterior segmentectomy5 (12.5)6 (15.0)0.1050.745
Right hepatectomy4 (10.0)4 (10.0)-1.0001
Left lateral sectionectomy + hilar cholangioplasty6 (15.0)7 (17.5)0.0920.762
Periportal hepatectomy + bilioenteric anastomosis4 (10.0)4 (10.0)-1.0001
Periportal hepatectomy + hilar cholangioplasty7 (17.5)8 (20.0)0.0820.775
Surgical time (minutes)250.0 (215.0-315.0)207.0 (185.8-255.0)-2.9840.003
Intraoperative blood loss (mL, IQR)290.0 (200.0-350.0)300.0 (250.0-450.0)-0.7910.429
Pringle maneuver time (minutes, IQR)35.0 (30.0-45.0)38.0 (25.0-45.0)-0.4450.656
Postoperative hospital stay (days, IQR)9.0 (8.0-11.0)14.0 (12.0-17.0)-5.545< 0.001
Stone clearance31 (77.5)32 (80.0)0.0750.785
Choledochoscopic stone removal via T-canal sinus9 (22.5)8 (20.0)0.0750.785
Final stone clearance 33 (82.5)34 (85.0)0.0920.762
Complications17 (42.5)18 (45.0)0.0510.822
Complication types
Intra-abdominal bleeding3 (7.5)3 (7.5)-1.0001
Biliary leakage3 (7.5)4 (10.0)-1.0001
Wound infection2 (5.0)9 (22.5)5.1650.023
Pulmonary infection3 (7.5)5 (12.5)-0.7121
Pleural effusion8 (20.0)10 (25.0)0.2870.592
Abdominal infection3 (7.5)6 (15.0)-0.4811
Subphrenic abscess1 (2.5)2 (5.0)-1.0001
Residual stones7 (17.5)8 (15.0)0.0920.762
Table 3 Postoperative follow-up outcomes in the laparoscopic and open surgery groups, n (%)
Variable
Laparoscopic group (n = 40)
Open surgery group (n = 40)
χ2/ Mann-Whitney U test
P value
Follow-up duration (months), mean ± SD28.0 (20.0-30.8)28.5 (24.0-40.5)-0.9470.344
Stone recurrence10 (25.0)7 (17.5)0.6720.412
Cholangitis8 (20.0)10 (25.0)0.2870.592
Cholangiocarcinoma3 (7.5)3 (7.5)-1.0001
Mortality0 (0.0)1 (2.5)-1.0001